You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons
|
---|---|
Published in |
Drug Discovery Today, April 2024
|
DOI | 10.1016/j.drudis.2024.104009 |
Pubmed ID | |
Authors |
Madura Kp Jayatunga, Margaret Ayers, Lotte Bruens, Dhruv Jayanth, Christoph Meier |
X Demographics
The data shown below were collected from the profiles of 359 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 94 | 26% |
United States | 14 | 4% |
Switzerland | 11 | 3% |
United Kingdom | 10 | 3% |
India | 6 | 2% |
Belgium | 6 | 2% |
Spain | 4 | 1% |
Canada | 3 | <1% |
Germany | 3 | <1% |
Other | 19 | 5% |
Unknown | 189 | 53% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 325 | 91% |
Scientists | 18 | 5% |
Practitioners (doctors, other healthcare professionals) | 8 | 2% |
Science communicators (journalists, bloggers, editors) | 8 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 43 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 23% |
Unspecified | 5 | 12% |
Student > Master | 4 | 9% |
Other | 3 | 7% |
Student > Bachelor | 2 | 5% |
Other | 4 | 9% |
Unknown | 15 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 6 | 14% |
Chemistry | 5 | 12% |
Unspecified | 4 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 7% |
Computer Science | 3 | 7% |
Other | 7 | 16% |
Unknown | 15 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 279. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2024.
All research outputs
#131,978
of 26,063,110 outputs
Outputs from Drug Discovery Today
#5
of 2,941 outputs
Outputs of similar age
#1,339
of 264,165 outputs
Outputs of similar age from Drug Discovery Today
#1
of 23 outputs
Altmetric has tracked 26,063,110 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,941 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 264,165 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.